Kearsley J - Search Results

1

Intralesional targeted alpha therapy for metastatic melanoma.

Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Graham P, Thompson JF, Reisfeld RA, Kearsley J. Allen BJ, et al. Among authors: kearsley j. Cancer Biol Ther. 2005 Dec;4(12):1318-24. doi: 10.4161/cbt.4.12.2251. Epub 2005 Dec 18. Cancer Biol Ther. 2005. PMID: 16322682 Free article. Clinical Trial.

2

Targeted alpha therapy for cancer.

Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Zhang D, Song E, Qu CF, Kearsley J, Graham P, Thompson J. Allen BJ, et al. Among authors: kearsley j. Phys Med Biol. 2004 Aug 21;49(16):3703-12. doi: 10.1088/0031-9155/49/16/016. Phys Med Biol. 2004. PMID: 15446799

3

Cytotoxicity of breast cancer cells overexpressing HER2/neu by 213Bi-Herceptin radioimmunoconjugate.

Zhang DY, Li Y, Rizvi SM, Qu C, Kearsley J, Allen BJ. Zhang DY, et al. Among authors: kearsley j. Cancer Lett. 2005 Feb 10;218(2):181-90. doi: 10.1016/j.canlet.2004.07.050. Cancer Lett. 2005. PMID: 15670895

4

Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma.

Raja C, Graham P, Abbas Rizvi SM, Song E, Goldsmith H, Thompson J, Bosserhoff A, Morgenstern A, Apostolidis C, Kearsley J, Reisfeld R, Allen BJ. Raja C, et al. Among authors: kearsley j. Cancer Biol Ther. 2007 Jun;6(6):846-52. doi: 10.4161/cbt.6.6.4089. Epub 2007 Mar 1. Cancer Biol Ther. 2007. PMID: 17495524 Free article. Clinical Trial.

5

Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205/Bismuth-206.

Abbas Rizvi SM, Song EY, Raja C, Beretov J, Morgenstern A, Apostolidis C, Russell PJ, Kearsley JH, Abbas K, Allen BJ. Abbas Rizvi SM, et al. Among authors: kearsley jh. Cancer Biol Ther. 2008 Oct;7(10):1547-54. doi: 10.4161/cbt.7.10.6538. Epub 2008 Oct 2. Cancer Biol Ther. 2008. PMID: 18708762 Free article.

6

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.

Chang L, Graham PH, Hao J, Bucci J, Cozzi PJ, Kearsley JH, Li Y. Chang L, et al. Among authors: kearsley jh. Cancer Metastasis Rev. 2014 Sep;33(2-3):469-96. doi: 10.1007/s10555-014-9493-5. Cancer Metastasis Rev. 2014. PMID: 24445654 Review.

7

Cancer stem cells in prostate cancer chemoresistance.

Ni J, Cozzi P, Hao J, Duan W, Graham P, Kearsley J, Li Y. Ni J, et al. Among authors: kearsley j. Curr Cancer Drug Targets. 2014;14(3):225-40. doi: 10.2174/1568009614666140328152459. Curr Cancer Drug Targets. 2014. PMID: 24720286

8

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells.

Xiao W, Graham PH, Hao J, Chang L, Ni J, Power CA, Dong Q, Kearsley JH, Li Y. Xiao W, et al. Among authors: kearsley jh. PLoS One. 2013 Aug 26;8(8):e74253. doi: 10.1371/journal.pone.0074253. eCollection 2013. PLoS One. 2013. PMID: 23991216 Free PMC article.

9

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y. Ni J, et al. Among authors: kearsley j. Int J Biochem Cell Biol. 2013 Dec;45(12):2736-48. doi: 10.1016/j.biocel.2013.09.008. Epub 2013 Sep 25. Int J Biochem Cell Biol. 2013. PMID: 24076216

10

CD44 is a biomarker associated with human prostate cancer radiation sensitivity.

Xiao W, Graham PH, Power CA, Hao J, Kearsley JH, Li Y. Xiao W, et al. Among authors: kearsley jh. Clin Exp Metastasis. 2012 Jan;29(1):1-9. doi: 10.1007/s10585-011-9423-7. Epub 2011 Sep 28. Clin Exp Metastasis. 2012. PMID: 21953074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters